The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>

Emma Forest, Jordan Lehoux, Alexandre Guy, Thierry Durand, Stéphane Audebert, Luc Camoin, Christopher D. Spilling, Céline Crauste, Stéphane Canaan, Jean Michel Brunel, Jean‐Michel Bolla, Jean‐François Cavalier

Open source

DOI
10.1002/mlf2.70014
Published
2025-06
Container
mLife
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mlf2.70014,
  title = {The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>},
  author = {Emma Forest and Jordan Lehoux and Alexandre Guy and Thierry Durand and Stéphane Audebert and Luc Camoin and Christopher D. Spilling and Céline Crauste and Stéphane Canaan and Jean Michel Brunel and Jean‐Michel Bolla and Jean‐François Cavalier},
  year = {2025},
  journal = {mLife},
  doi = {10.1002/mlf2.70014},
  url = {https://doi.org/10.1002/mlf2.70014}
}

RIS

TY  - JOUR
TI  - The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>
AU  - Emma Forest
AU  - Jordan Lehoux
AU  - Alexandre Guy
AU  - Thierry Durand
AU  - Stéphane Audebert
AU  - Luc Camoin
AU  - Christopher D. Spilling
AU  - Céline Crauste
AU  - Stéphane Canaan
AU  - Jean Michel Brunel
AU  - Jean‐Michel Bolla
AU  - Jean‐François Cavalier
PY  - 2025
JO  - mLife
DO  - 10.1002/mlf2.70014
UR  - https://doi.org/10.1002/mlf2.70014
ER  - 

APA

Forest, E., Lehoux, J., Guy, A., Durand, T., Audebert, S., Camoin, L., Spilling, C. D., Crauste, C., Canaan, S., Brunel, J. M., Bolla, J., & Cavalier, J. (2025). The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>. mLife. https://doi.org/10.1002/mlf2.70014

Source records